Independent
Tenure on this board
9.7 yrs
Meeting calendar
CYPH · Annual meeting · Thursday, June 18, 2026
Cypherpunk Technologies Inc
2 nominees · 3 ballot items.
Election of two Class III directors; advisory (non-binding) approval of executive compensation (Say-on-Pay); and ratification of appointment of EisnerAmper LLP as independent auditors for 2026.
Market cap
$303M
1Y TSR
+442.1%
Board grade
C-
Record date
Apr 29, 2026
Filing
DEF 14A
Meeting concluded · Jun 18, 2026
Follow how the vote landed and what changed on Cypherpunk Technologies Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of two Class III directors, Nissim Mashiach and Will McEvoy, each to serve until 2029.
- 2
Advisory Non-Binding Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORAdvisory, non-binding vote to approve compensation of named executive officers as disclosed.
More detail
This is an advisory, non-binding vote required by Section 14A of the Exchange Act and the Dodd-Frank Act, asking stockholders to approve the compensation disclosed for named executive officers. Management seeks shareholder feedback on pay practices; the vote does not bind the company but the compensation committee and Board will consider the outcome. The company’s compensation program is designed to attract and retain executives and align them with stockholder interests through base salary, annual cash bonuses based on corporate objectives, and long-term equity incentives. Notable context includes significant RSU grants in 2025 to executives (e.g., large RSU grants to the CEO and CIO), a pay-versus-performance disclosure showing CAP outpaced net loss in certain years, and the company’s status as a smaller reporting company. The Board recommends FOR given the committee’s role in setting and reviewing pay, the use of market data and an external consultant, and the incorporation of compensation policies like clawback/recoupment per Nasdaq rules. Stockholders should weigh concentrated equity awards and recent governance changes when deciding whether advisory approval supports current compensation philosophy.
- 3
Ratification of Selection of Independent Registered Public Accounting Firm
ManagementBoard: FORRatify appointment of EisnerAmper LLP as independent auditors for the year ending December 31, 2026.
Director elections
Nominees on the ballot2
Not independent
Tenure on this board
0.9 yrs
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 3,887,574 | $2M |
| 2 | BlackRock, Inc. | 2.4% | 2,622,823 | $2M |
| 3 | JANE STREET GROUP, LLC | 1.1% | 1,200,476 | $735K |
| 4 | UBS Group AG | 1.0% | 1,071,847 | $656K |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 0.8% | 873,464 | $535K |
| 6 | CITADEL ADVISORS LLC | 0.8% | 836,153 | $512K |
| 7 | XTX Topco Ltd | 0.6% | 638,329 | $391K |
| 8 | VANGUARD FIDUCIARY TRUST CO | 0.5% | 571,345 | $350K |
| 9 | STATE STREET CORP | 0.5% | 516,113 | $316K |
| 10 | JANE STREET GROUP, LLC | 0.5% | 501,450 | $307K |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Cypherpunk Technologies Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Angiodynamics IncANGO
Annual meeting·Nov 17, 2026·$464M
Tilray Brands IncTLRY
Annual meeting·Nov 18, 2026·$489M
Weave Communications IncWEAV
Special meeting·Oct 22, 2026·$591M
Varex Imaging CorpVREX
Special meeting·Oct 28, 2026·$778M
Phibro Animal Health CorpPAHC
Annual meeting·Nov 3, 2026·$1.5B
Supernus Pharmaceuticals IncSUPN
Special meeting·Oct 15, 2026·$2.4B
Reference
Frequently asked questions
- When is the Cypherpunk Technologies Inc 2026 annual meeting?
- Cypherpunk Technologies Inc (CYPH) holds its 2026 annual shareholder meeting on Thursday, June 18, 2026.
- What is the record date for the Cypherpunk Technologies Inc 2026 meeting?
- The record date for the Cypherpunk Technologies Inc 2026 meeting is Wednesday, April 29, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Cypherpunk Technologies Inc's 2026 meeting?
- The board is presenting 2 director nominees at the Cypherpunk Technologies Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Cypherpunk Technologies Inc 2026 meeting?
- Shareholders will vote on 3 proposals at the Cypherpunk Technologies Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.